Business
– The Phase III trial results showed significant improvement in the treatment of chronic low back pain. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...
Hi, what are you looking for?
– The Phase III trial results showed significant improvement in the treatment of chronic low back pain. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...
– Type 1 diabetes currently plagues 25.8 million Americans of all ages, about 8.3 percent of the U.S. population, according to the National Diabetes...
– Teva CSO Dr. Michael Hayden: We are disappointed with these results. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) today announced...
– Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment in Japan. – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Takeda Pharmaceutical Company...
– Biting into Whole Foods Can Make Children Rowdy. – The researchers note that when children need to bite into food with their front...
– Increased link to mental disorders, suicidal thoughts and suicide attempts. – – Almost one-third of adults in Canada have experienced child abuse —...
– Ultrasound Device Identifies High-Risk Arterial Plaque – Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have...
– Hyperion Therapeutics (Nasdaq:HPTX) announced today that it acquires Andromeda Biotech Ltd., an Israel-based subsidiary of Clal Biotechnology Industries Ltd. (TASE:CBI), for $20 million...
– Inspiromatic Improves Drug Delivery, Monitors Patient Inhalation and Provides Real-Time Patient Feedback. – – OPKO Health, Inc. (NYSE:OPK) has entered into a definitive...
– Brand Celebrex has $2.2 billion in US sales in 2013, according to IMS data. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that its...